Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

B&E Scientific

B&E Scientific designs, manufactures and markets products for clinical diagnostic applications. It offers hematology ... read more Featured Products: More products

Download Mobile App





B&E Bio-Technology Presents Hematology and Clinical Diagnostic Analyzers

By LabMedica International staff writers
Posted on 17 Nov 2026

B&E Bio-Technology (Yantai, Shandong, China) is showcasing its portfolio of laboratory and point-of-care diagnostic instruments at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. More...

At Hall 3, Stand F92-5, the company is highlighting five systems covering hematology, blood gas testing, electrolyte measurement, and glycated hemoglobin analysis. These instruments are designed to support routine laboratory testing, patient monitoring, and decentralized diagnostic applications.

Among the featured products is the Hemax 530AL automatic hematology analyzer, a five-part differential system capable of measuring 29 parameters at a throughput of up to 80 samples per hour. The analyzer combines semiconductor laser flow cytometry, electrical impedance, and cyanide-free hemoglobin measurement. It features an automatic sample loader, supports whole blood and capillary blood testing with sample volumes of 20 µL or less, and offers bidirectional laboratory information system (LIS) connectivity. B&E is also presenting the Hemax 580, another automated hematology analyzer designed to support routine blood cell analysis and differential leukocyte counting in clinical laboratories.

For point-of-care testing, B&E is highlighting the handheld i-Check 200 blood gas analyzer, which uses disposable cartridges and dry electrochemical measurement technology. The portable system measures blood gases, electrolytes, glucose, lactate, hematocrit, and other parameters using approximately 95 µL of blood, with results available in 60 seconds or less. It supports arterial, venous, and capillary blood samples and is designed for use in settings such as emergency departments, intensive care units, and bedside testing.

The company is also exhibiting its CBS Series electrolyte analyzers, which incorporate an all-in-one biosensor electrode design for electrolyte testing. These instruments support the measurement of electrolyte concentrations to assist in assessing fluid and electrolyte balance. Their integrated electrode configuration is intended to simplify routine testing and instrument operation.

Completing the exhibit is the G60 glycated hemoglobin analyzer, which uses high-performance liquid chromatography (HPLC) to measure hemoglobin A1c (HbA1c). The system provides laboratory measurements used in diabetes diagnosis and long-term glycemic monitoring. Together, these five instruments reflect B&E Bio-Technology's portfolio of automated and point-of-care diagnostic technologies for clinical laboratory and healthcare applications.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.